Clinical trial
Anakinra to Treat Patients With Neonatal Onset Multisystem Inflammatory Disease
NCT00069329 · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH · Terminated
Key facts
| NCT number | NCT00069329 |
|---|---|
| Title | Anakinra to Treat Patients With Neonatal Onset Multisystem Inflammatory Disease |
| Official title | A Long-Term Outcome Study With the IL-1 Receptor Antagonist Anakinra/Kineret in Patients With Neonatal Onset Multisystem Inflammatory Disease (NOMID/CINCA Syndrome) A Therapeutic Approach to Study the Pathogenesis of This Disease |
| Lead sponsor | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Nervous System Malformations, Arthropathy, Neurogenic, Urticaria, Papilledema |
| Intervention type | Drug |
| Interventions | anakinra |
| Enrollment | 43 |
| Start date | Sep 1, 2003 |
| Primary completion | Apr 1, 2010 |
| Completion | Apr 1, 2010 |
| First posted | Sep 23, 2003 |
| Last update posted | Dec 1, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: